ASX:EVEFood, Beverage & TobaccoPackaged Foods & Meats
Eve Health Group Ltd
$0.019
Day Range
$0.019 – $0.019
52 Week Range
$0.017 – $0.036
Volume
14.20K
Avg Volume (10D)
135.38K
Market Cap
$6.69M
Price Chart
Market Statistics
Open$0.019
Previous Close$0.019
Day High$0.019
Day Low$0.019
52 Week High$0.036
52 Week Low$0.017
Valuation
Market Cap6.69M
Shares Outstanding352.33M
Price to Book1.44
Trading Activity
Volume14.20K
Value Traded269.71
Bid$0.019 × 161,871
Ask$0.020 × 200,000
Performance
1 Day0.00%
5 Day-7.32%
13 Week-17.39%
52 Week-38.71%
YTD-9.52%
Technical Indicators
RSI (14)32.49
50-Day SMA$0.025
200-Day SMA$0.025
Latest News
Biotechnology
EVE Health Group Initiates Pilot Study of Libbo Oral Soluble Film to Treat ED
EVE Health launches pilot Libbo ED study (oral soluble film), a key bioequivalence step toward regulatory approval; results expected by end-September. ASX:EVE
Biotechnology
EVE Health Appoints New CEO to Lead Company Through Next Phase of Growth
EVE Health appoints COO Ben Rohr as new CEO to drive next growth phase and accelerate commercialisation; Damian Wood shifts to regulatory/medical affairs.
Biotechnology
EVE Health Increases Capital Raising to $1.3m with $400,000 Cornerstone Investment
EVE Health Group lifts capital raise to $1.3m with $400k cornerstone, signalling reformulated-drug strategy and new science adviser amid Libbo launch.
Biotechnology
EVE Health Group Raises $0.9m to Advance Reformulated Pharmaceutical Pipeline
EVE Health Group raises $0.904m via placement to push reformulated drug delivery pipeline, accelerating IP, regulatory work and licensing talks.